In 2017, David G. Lowe earned $506.89K in total compensation at Spyre Therapeutics, Inc., primarily from $278.10K salary.
Compensation History
Annual executive compensation data for David G. Lowe, including salary, bonuses, and stock awards.
Year
2017
Total Compensation
$506.89K
Salary
$278.10K
Bonus
$0.00
Other
$228.79K
Salary
$278.10KBoard Justification
N/A
Bonus
$0.00Board Justification
N/A
Other Compensation
$228.79KBoard Justification
Represents (i) severance payments made to Dr. Lowe in connection with his resignation in July 2017 of $214,414 and (ii) health insurance premiums paid by us in the applicable period on behalf of Dr. Lowe of $14,376.
Restricted Stock
Board Justification
N/A
Performance Metrics
N/A
David G. Lowe
Ex-CEO of Spyre Therapeutics, Inc.
Sector of Economy
Healthcare
CEO of Spyre Therapeutics, Inc. for
0 years 0 months (Jul 2017 - Jul 2017)
Previous Experience
Unknown
Other Spyre Therapeutics, Inc. CEOs
Holdings
Track David G. Lowe's stock holdings and portfolio value over time.
Insider Trading
David G. Lowe's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare David G. Lowe with competitor CEOs and industry peers.